India's latest essential medicines list: gaps, strengths and opportunities in evidence-based decision-making.
In: BMJ evidence-based medicine, Jg. 28 (2023-10-01), Heft 5, S. 303-305
academicJournal
Zugriff:
Competing Interests: Competing interests: VJ is listed as a contributor to the expert consultations on the report of the Standing National Committee on Medicines for the revision of National List of Essential Medicines. VJ has received grant funding from GSK, Baxter Healthcare, and Biocon and honoraria from Bayer, AstraZeneca, Boeringer Ingelheim, NephroPlus, and Zydus Cadilla, under the policy of all honoraria being paid to the organization.
Titel: |
India's latest essential medicines list: gaps, strengths and opportunities in evidence-based decision-making.
|
---|---|
Autor/in / Beteiligte Person: | Satheesh, G ; Unnikrishnan, MK ; Jha, V ; Salam, A |
Zeitschrift: | BMJ evidence-based medicine, Jg. 28 (2023-10-01), Heft 5, S. 303-305 |
Veröffentlichung: | [London] : BMJ Publishing Group, [2018]-, 2023 |
Medientyp: | academicJournal |
ISSN: | 2515-4478 (electronic) |
DOI: | 10.1136/bmjebm-2022-112171 |
Schlagwort: |
|
Sonstiges: |
|